About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pennsylvania | 30,724 Studies Near You

Clinical TrialsPennsylvania

Clinical Trials in Pennsylvania

Discover 30,724 clinical trials near Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 301-320 of 30,724 trials

Active not recruitingStudy of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS MutationThe purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effective, and to assess the safety, efficacy…NCT06106308·Phoenix, Arizona and 40 others

Find Trials by Condition in Pennsylvania

Breast Cancerin Pennsylvania Lung Cancerin Pennsylvania Prostate Cancerin Pennsylvania Colorectal Cancerin Pennsylvania Melanomain Pennsylvania Leukemiain Pennsylvania Lymphomain Pennsylvania Pancreatic Cancerin Pennsylvania Ovarian Cancerin Pennsylvania Brain Cancerin Pennsylvania

Data from ClinicalTrials.govTerms

CompletedIntegrating Palliative Care for Patients With Idiopathic Pulmonary Fibrosis and Their CaregiversPatients with Idiopathic Pulmonary Fibrosis (IPF) and their caregivers will be randomized to receive this intervention or usual care.NCT02929017·Pittsburgh, Pennsylvania

CompletedStudy of Nerve Repair and Reconstruction Associated With Major Extremity TraumaThis is a multi-center prospective observational study that will capture detailed information about the treatment and long term outcomes of 250 patients with PNI resulting from…NCT02718768·Denver, Colorado and 16 others

Active not recruitingA Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.This is a parallel, Phase 3, two-arm study for the treatment of newly diagnosed moderate or severe chronic GVHD.NCT06143891·Little Rock, Arkansas and 150 others

RecruitingALS20-101 Lentiviral Gene Therapy for Beta ThalassemiaThe main goal of this study is to find out if the blood disorder called transfusion-dependent beta thalassemia can be safely treated by modifying blood stem cells.NCT06364774·Philadelphia, Pennsylvania

CompletedHPPH and PDT for Pleural MalignancyThe primary objective of the study is to determine the maximally tolerated photodynamic therapy (PDT) dose and drug-light interval of PDT using light and HPPH in patients with…NCT01673074·Philadelphia, Pennsylvania

CompletedDose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)The purpose of the study is to determine the efficacy and safety of Perampanel (E2007) in patients with Post-Herpetic Neuralgia (PHN).NCT00592774·Peoria, Arizona and 46 others

CompletedLurasidone HCl: A Phase 3 Study of Patients With Acute SchizophreniaLurasidone HCl is a compound being developed for the treatment of schizophrenia.NCT00549718·Little Rock, Arkansas and 47 others

CompletedA Study of Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow DisordersAnagrelide is a drug that has been shown to slow down how fast platelets are made in the bone marrow, and has been approved by the FDA for treating high platelets counts in…NCT02125318·Burbank, California and 10 others

Active not recruitingStudy of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects…NCT04065490·Beverly Hills, California and 10 others

CompletedMarimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following ChemotherapyRATIONALE: Marimastat may stop the growth of breast cancer by stopping blood flow to the tumor.NCT00003010·Scottsdale, Arizona and 24 others

CompletedBevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade GliomaThis phase II trial is studying how well giving bevacizumab together with irinotecan works in treating young patients with recurrent, progressive, or refractory glioma…NCT00381797·San Francisco, California and 10 others

RecruitingTrastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorThis phase I/II trial studies the effects of trastuzumab deruxtecan (DS-8201a) in treating patients with osteosarcoma, Wilms tumor (WT) or desmoplastic small round cell tumor…NCT04616560·Birmingham, Alabama and 29 others

CompletedA Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305)This randomized, multi-center double-blind, parallel-group, placebo-controlled study will evaluate the efficacy and safety of RO4917838 (bitopertin) in patients with sub-optimally…NCT01235559·Costa Mesa, California and 89 others

CompletedPerspectives on Prophylactic Antibiotic Use in Dermatologic SurgeryThis is a prospective, multi-center observational survey study to uncover how antibiotic differences can influence utilization decisions.NCT04150523·Davis, California and 7 others

RecruitingA Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal CancerA Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients with Refractory Advanced/Metastatic Microsatellite Stable Colorectal CancerNCT06992258·New Haven, Connecticut and 12 others

CompletedUtilizing Novel Information Technology to Promote Exercise and Well-Being in Adolescents and Young Adults With CancerAdolescents and young adults (AYAs) with cancer have many needs for supportive care that differ from younger and older patients.This includes age-appropriate psychological support…NCT03778658·Hershey, Pennsylvania

CompletedDrug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast CancerRATIONALE: Some tumors become resistant to chemotherapy drugs. Combining PSC 833 with a chemotherapy drug may reduce resistance to the drug, and allow the tumor cells to be killed.NCT00002826·Palo Alto, California and 8 others

RecruitingA Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung CancerThis is a Phase II, Open Label, Multicenter, Single Arm Study of WSD0922-FU for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer whose Disease has…NCT06868485·Oxnard, California and 17 others

TerminatedTrial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial MeningiomaIn this multicenter, Phase II trial, the investigators plan to evaluate the activity of the combination of bevacizumab and everolimus in patients with recurrent, progressive…NCT00972335·Orlando, Florida and 6 others

PreviousPage 16 of 1537Next

Diabetes

in Pennsylvania

Heart Diseasein Pennsylvania